1 / 11

Outcome of 23-gauge sutureless transconjunctival vitrectomy for endophthalmitis

Outcome of 23-gauge sutureless transconjunctival vitrectomy for endophthalmitis. Dr Colin S.H. Tan. Acknowledgments. Dr Hon Kiat WONG Dr Francine YANG Dr Jong Jian LEE The authors have no financial or proprietary interests in the subject of this poster. Introduction.

neveah
Download Presentation

Outcome of 23-gauge sutureless transconjunctival vitrectomy for endophthalmitis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Outcome of 23-gauge sutureless transconjunctival vitrectomy for endophthalmitis Dr Colin S.H. Tan

  2. Acknowledgments • Dr Hon Kiat WONG • Dr Francine YANG • Dr Jong Jian LEE • The authors have no financial or proprietary interests in the subject of this poster

  3. Introduction • Endophthalmitis is a potentially devastating eye infection • Postoperative endophthalmitis reported in between 0.04% to 0/12% of cases • Vitrectomy may be useful in treatment of endophthalmitis, especially with visual acuity of light perception or worse. • No previous report on use of 23-G sutureless vitrectomy to treat endophthalmitis

  4. Objectives • To review the feasibility and surgical outcomes of using 23G transconjunctival vitrectomy for the treatment of endophthalmitis

  5. Methods • Non-randomized, interventional case series study • All patients presenting with postoperative endophthalmitis over a 1-year period from April 2005 to March 2006 • Main outcome measures: intraoperative and posteroperative complications (hypotony, wound leak, chemosis)

  6. Results • Vitrectomy was performed on 6 patients (4 acute and 2 chronic endophthalmitis) • Mean surgical time 58.3 minutes (range 40 – 75) • Mean follow-up 13.2 months (range, 9 –17)

  7. Surgical outcomes • Thorough clearance of the vitreous base was achieved • No severe postoperative pain • No wound leak / hypotony • Mean IOP on 1st postoperative day was 17.3 mmHg (SD  3.4, range, 12 – 21 mmHg) • Mean IOP change-4.2 mmHg compared to the preoperative IOP (p=0.239)

  8. Visual outcomes • ≥ 20/40 in 5 of 6 patients (83.3%) overall • ≥ 20/40 in 3 of 4 patients (75%) with acute endophthalmitis • Final visual acuity (VA) significantly improved compared to preoperative VA (p=0.026)

  9. Characteristics of patients

  10. Discussion • Advantages of transconjunctival vitrectomy: • Reduced surgical time • Less postoperative discomfort • Shorter recovery time • Concern about postoperative hypotony due to sutureless sclerostomy • Able to clear vitreous base without difficulty using 23-gauge instruments

  11. Conclusion • 23-gauge transconjunctival vitrectomy can be performed safely for both acute and chronic endophthalmitis • Good final visual acuity • No cases of hypotony or severe complications

More Related